Sharon M Kelly1, Robert P Schwartz2, Kevin E O'Grady3, Shannon G Mitchell4, Tiffany Duren5, Anjalee Sharma6, Jerome H Jaffe7. 1. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, USA. Electronic address: skelly@friendsresearch.org. 2. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, USA. Electronic address: rschwartz@friendsresearch.org. 3. Department of Psychology, University of Maryland, College Park, MD, USA. Electronic address: ogrady@umd.edu. 4. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, USA. Electronic address: smitchell@friendsresearch.org. 5. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, USA. Electronic address: tduren@friendsresearch.org. 6. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, USA. Electronic address: asharma@friendsresearch.org. 7. Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, USA. Electronic address: jhjaffe@aol.com.
Abstract
BACKGROUND: There are limited data from randomized trials about the impact of starting methadone treatment in jail on subsequent arrest after release for adults with opioid use disorder (OUD). METHODS: Official arrest records were obtained for 212 participants with OUD who were enrolled in a three-group randomized controlled trial of initiating methadone treatment in jail either with or without patient navigation vs. enhanced treatment-as-usual in Baltimore, Maryland. Participants treated for opioid withdrawal in jail were assigned to: 1) interim methadone (IM) with patient navigation (PN; IM + PN); 2) IM without PN (IM); or 3) enhanced treatment-as-usual (ETAU). Participants in both IM groups were able to continue treatment at a community-based methadone treatment program with counseling upon release, while ETAU participants received overdose information and a city-wide treatment assessment/referral number. Likelihood of arrest, time to first subsequent arrest, andseverity of arrest charges in the 12 months following release were examined for: 1) combined IM + PN and IM groups compared to ETAU; and 2) IM + PN compared to IM. RESULTS: Within 12 months of release from the index incarceration, 50.5% of the sample had been arrested. The majority of arrest charges (71%) were for low-level, nonviolent crimes. On an intention-to-treat basis, there were no significant differences between the combined IM + PN and IM groups vs. ETAU or IM + PN vs. IM in the likelihood of arrest, time to first subsequent arrest, or severity of arrest charges. CONCLUSION: Initiating IM with or without PN during pretrial detention did not have a significant effect on subsequent arrest during a 12-month post-release follow-up compared to not starting methadone maintenance during detention, despite the high rate of methadone treatment entry in the community following release. This finding may be attributable to the considerable attrition from treatment in the community or other systematic factors. Additional interventions may be needed to reduce the likelihood of subsequent arrest.
RCT Entities:
BACKGROUND: There are limited data from randomized trials about the impact of starting methadone treatment in jail on subsequent arrest after release for adults with opioid use disorder (OUD). METHODS: Official arrest records were obtained for 212 participants with OUD who were enrolled in a three-group randomized controlled trial of initiating methadone treatment in jail either with or without patient navigation vs. enhanced treatment-as-usual in Baltimore, Maryland. Participants treated for opioid withdrawal in jail were assigned to: 1) interim methadone (IM) with patient navigation (PN; IM + PN); 2) IM without PN (IM); or 3) enhanced treatment-as-usual (ETAU). Participants in both IM groups were able to continue treatment at a community-based methadone treatment program with counseling upon release, while ETAUparticipants received overdose information and a city-wide treatment assessment/referral number. Likelihood of arrest, time to first subsequent arrest, and severity of arrest charges in the 12 months following release were examined for: 1) combined IM + PN and IM groups compared to ETAU; and 2) IM + PN compared to IM. RESULTS: Within 12 months of release from the index incarceration, 50.5% of the sample had been arrested. The majority of arrest charges (71%) were for low-level, nonviolent crimes. On an intention-to-treat basis, there were no significant differences between the combined IM + PN and IM groups vs. ETAU or IM + PN vs. IM in the likelihood of arrest, time to first subsequent arrest, or severity of arrest charges. CONCLUSION: Initiating IM with or without PN during pretrial detention did not have a significant effect on subsequent arrest during a 12-month post-release follow-up compared to not starting methadone maintenance during detention, despite the high rate of methadone treatment entry in the community following release. This finding may be attributable to the considerable attrition from treatment in the community or other systematic factors. Additional interventions may be needed to reduce the likelihood of subsequent arrest.
Authors: S R Yancovitz; D C Des Jarlais; N P Peyser; E Drew; P Friedmann; H L Trigg; J W Robinson Journal: Am J Public Health Date: 1991-09 Impact factor: 9.308
Authors: Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes Journal: Arch Gen Psychiatry Date: 2006-01
Authors: Stephen Magura; Joshua D Lee; Jason Hershberger; Herman Joseph; Lisa Marsch; Carol Shropshire; Andrew Rosenblum Journal: Drug Alcohol Depend Date: 2008-10-18 Impact factor: 4.492
Authors: Robert P Schwartz; Sharon M Kelly; Shannon Gwinn Mitchell; Jan Gryczynski; Kevin E O'Grady; Jerome H Jaffe Journal: Drug Alcohol Depend Date: 2017-09-14 Impact factor: 4.492
Authors: Christine E Grella; Erika Ostlie; Dennis P Watson; Christy K Scott; John Carnevale; Michael L Dennis Journal: J Subst Abuse Treat Date: 2022-01-04
Authors: Shannon Gwin Mitchell; Caroline Harmon-Darrow; Elizabeth Lertch; Laura B Monico; Sharon M Kelly; James L Sorensen; Robert P Schwartz Journal: J Subst Abuse Treat Date: 2021-03-04